Roivant Sciences to hold Annual General Meeting on September 16, 2026
Roivant Sciences Ltd. announced its 2026 Annual General Meeting of Shareholders (AGM) will take place on September 16, 2026, in London. Key proposals for shareholder vote include the election of two Class II directors, Daniel Gold and Meghan FitzGerald, and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2027. Additionally, shareholders will cast a non-binding advisory vote on executive compensation. The record date for shareholders entitled to vote is July 23, 2026.
Key Highlights
- Annual General Meeting (AGM) to be held on September 16, 2026, at 10:30 a.m. UK local time.
- AGM location: Royal Lancaster London Hotel, Lancaster Terrace, London W2 2TY, United Kingdom.
- Shareholders to elect two Class II directors: Daniel Gold and Meghan FitzGerald.
- Proposal to ratify Ernst & Young LLP as independent auditor for fiscal year ending March 31, 2027.
- Non-binding, advisory vote to approve compensation of named executive officers.
- Record date for voting at the AGM is July 23, 2026.
- Board of Directors consists of 8 members, with 6 determined as independent.
Price Impact
More from ROIV
Roivant's Brepocitinib gets FDA Priority Review for DM; $2.25B Moderna Settlement
Roivant Sciences Q4 Income $355.7M; $2.25B Moderna Settlement
Roivant reaches $2.25B Moderna settlement; IMVT-1402 shows strong D2T RA data